{{Rsnum
|rsid=11730582
|Gene=SPP1
|Chromosome=4
|position=87975269
|Orientation=plus
|GMAF=0.3407
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SPP1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 18.6 | 54.0 | 27.4
| HCB | 13.9 | 39.4 | 46.7
| JPT | 12.4 | 52.2 | 35.4
| YRI | 0.0 | 9.5 | 90.5
| ASW | 5.3 | 12.3 | 82.5
| CHB | 13.9 | 39.4 | 46.7
| CHD | 5.5 | 46.8 | 47.7
| GIH | 27.7 | 49.5 | 22.8
| LWK | 0.0 | 9.1 | 90.9
| MEX | 31.0 | 50.0 | 19.0
| MKK | 1.9 | 21.8 | 76.3
| TSI | 19.6 | 48.0 | 32.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=20075512
|Title=Genetic variation in osteopontin gene is associated with susceptibility to sarcoidosis in Slovenian population
|OA=1
}}

{{PMID Auto
|PMID=22131818
|Title=Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus
|OA=1
}}

{{PMID Auto
|PMID=18335026
|Title=Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction.
|OA=1
}}

{{PMID Auto
|PMID=19339987
|Title=Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.
|OA=1
}}

{{PMID Auto
|PMID=21396799
|Title=Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw.
}}

{{PMID Auto
|PMID=22584029
|Title=Association of an Osteopontin gene promoter polymorphism with susceptibility to diabetic nephropathy in Asian Indians.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}